Skip links

Immuno UK, March 28-29, 2023, London, UK

Participating in the Immuno 2023 in London from March 28-29th? Be sure to attend the presentation by our CSO, Michael Thiele entitled “Targeting oxMIF in autoimmune diseases” on March 28 from 11:10 – 11:35 am GMT. Participants will have the opportunity to learn more about the promising potential of our novel bioengineered monoclonal antibody ON104 targeting oxMIF as a novel treatment approach for autoimmune diseases and meet with Michael and our Director Precinical Christine Landlinger-Schubert.

Home